2023-11-07T20:04:32-08:00 2023-06-30 352317502 Bunker & Company LLP 4340 Redwood Hwy Suite 117 San Rafael CA 94903 990 2022-07-01 942495035 GLAUCOMA RESEARCH FOUNDATION GLAU 4159863162 251 POST STREET STE 600 SAN FRANCISCO CA 94108 THOMAS M BRUNNER President & CEO 2023-11-07 true THOMAS M BRUNNER 999009999 true Joseph C Bunker P00204452 4154997661 2 AAL1 IAL1 FAL1 2022 2023-04-26 12:10:37Z THOMAS M BRUNNER 251 POST STREET STE 600 SAN FRANCISCO CA 94108 6819307 false X www.glaucoma.org X 1978 CA Cure Glaucoma and restore vision through innovative research. 14 13 11 25 0 5011182 5620842 504039 391050 68754 269744 193199 198831 5777174 6480467 1863969 2443328 0 1551106 1863819 0 582427 1522325 1851780 4937400 6158927 839774 321540 13065899 14426054 944864 1531113 12121035 12894941 Cure Glaucoma and restore vision through innovative research. false false 5387181 2443328 THE ORGANIZATION PROMOTES AND SUPPORTS RESEARCH AND EDUCATION CONCERNING THE CAUSES AND TREATMENT OF GLAUCOMA. IT HAS BEEN A LEADER IN COLLABORATIVE RESEARCH THROUGH THE LANDMARK MULTI-CENTER NORMAL TENSION GLAUCOMA STUDY WHICH TRANSFORMED GLAUCOMA TREATMENT, AS WELL AS THE CREATION OF THE "CATALYST FOR A CURE" (CFC). THIS UNIQUE RESEARCH MODEL BRINGS TOGETHER SCIENTISTS FROM DIFFERENT DISCIPLINES TO WORK TOGETHER TO UNDERSTAND GLAUCOMA AND FIND WAYS TO IMPROVE TREATMENT AND FIND A CURE. THE FIRST CFC TEAM MADE A SIGNIFICANT IMPACT ON THE FIELD OF GLAUCOMA AND HELPED TO TRANSFORM THE UNDERSTANDING OF GLAUCOMA FROM AN EYE DISEASE TO A NEURODEGENERATIVE DISEASE.TAKING THE FINDINGS FROM THE FIRST TEAM, A SECOND CFC TEAM WAS CREATED TO DEVELOP NEW BIOMARKERS TO DIAGNOSE AND MANAGE GLAUCOMA MORE EFFECTIVELY BEFORE VISION IS LOST AND OPEN PATHWAYS TO NEW TREATMENT OPTIONS FOR PATIENTS. A third CFC Team was launched to discover ways to restore vision lost to glaucoma by restoring, regenerating or replacing the retinal ganglion cells damaged in glaucoma.A fourth CFC team was launched in July to investigate common mechanisms of glaucoma and Alzheimer's to prevent and cure these and other neurodegenerative diseases. THE ORGANIZATION ALSO PROVIDES FUNDING FOR INNOVATIVE PILOT STUDIES IN GLAUCOMA RESEARCH. THESE INCUBATOR GRANTS ENABLE SCIENTISTS TO INVESTIGATE A NOVEL AND PROMISING IDEA AND GATHER CRITICAL DATA TO CONTINUE THEIR RESEARCH AND SECURE ADDITIONAL FUNDING. THIS PROGRAM CONTINUES TO NURTURE THE CAREERS OF PROMISING GLAUCOMA INVESTIGATORS AND BRING NEW IDEAS TO THE FIELD OF GLAUCOMA RESEARCH. IN ADDITION, THE ORGANIZATION SERVES AS A PRIMARY SOURCE OF INFORMATION AND SUPPORT FOR PATIENTS BY PROVIDING UNBIASED EDUCATIONAL MATERIALS IN PRINT AND ONLINE. 5387181 true true false false false false false false false true true false false true true false true false false false true true false false true false false true false true false false false false false false false false true false false false false false false false false true 21 0 false 11 true false false false false false true true false 0 false false false false false false false X 14 13 false false false false false false false true true false false true true true true true true true true false CA X X X GLAUCOMA RESEARCH FOUNDATION 4159863162 251 POST ST 600 SAN FRANCISCO CA 94108 THOMAS M BRUNNER President & CEO 32.00 0.00 X X 258086 0 13140 NANCY GRAYDON E.D. DEVEL. & COO 40.00 0.00 244991 0 12500 ANDREW JACKSON DIR. COMMUNICATION 40.00 0.00 141649 0 7306 CATALINA SAN AGUSTIN DIRECTOR OPERATION 40.00 0.00 139092 0 7175 Morgan Velarde Dir. Philanthropic 40.00 0.00 104261 0 5554 Michelle De Elizalde Epstein Asst. Dir. Researc 40.00 0.00 100219 0 4472 ANDREW G IWACH MD CHAIR 2.00 0.00 X X 0 0 0 RUTH D WILLIAMS MD VICE CHAIR 2.00 0.00 X X 0 0 0 CHARLES R WILMOTH Treasurer 2.00 0.00 X X 0 0 0 Richard HALPRIN CPA Secretary 2.00 0.00 X X 0 0 0 FREDERICK H BRINKMANN Director 2.00 0.00 X 0 0 0 Nancy S Forster Director 2.00 0.00 X 0 0 0 Oluwatosin Smith Director 2.00 0.00 X 0 0 0 ROBERT L STAMPER MD Director 2.00 0.00 X 0 0 0 DENNIS E SINGLETON Director 2.00 0.00 X 0 0 0 LINDA C LINCK Director 2.00 0.00 X 0 0 0 ADRIENNE L GRAVES PHD Director 2.00 0.00 X 0 0 0 John G Flanagan PHD Director 2.00 0.00 X 0 0 0 Terri-Diann Pickering MD Director 2.00 0.00 X 0 0 0 988298 50147 6 false true false Bryn Mawr Communications 1008 Upper Gulph Rd Wayne PA 19087 Advertising 164844 Jacqueline Jones Design 346 G St San Rafael CA 94901 Graphic Design, Printing 371697 2 5620842 90157 5620842 CONFERENCE/FORUM 391050 391050 391050 269430 269430 0 0 0 314 314 314 314 523635 338840 184795 184795 0 0 MISCELLANEOUS 14036 14036 14036 6480467 405086 454539 2393328 2393328 0 50000 50000 0 271226 235967 8137 27122 0 1592593 1268856 100023 223714 0 0 0 0 0 0 0 0 0 0 0 0 0 0 213749 172559 12446 28744 0 0 0 0 0 0 0 OTHER EXPENSES 813801 695314 26240 92247 OPERATING EXPENSES 559218 368928 17063 173227 CONSULTING EXPENSES 265012 202229 25410 37373 0 6158927 5387181 189319 582427 1002187 246975 1857221 1958254 2867546 3547953 0 0 0 0 13288 27390 115373 226200 290576 126858 128096 163718 3673279 4468105 0 0 0 3408909 3787459 13065899 14426054 182364 224948 762500 925000 381165 944864 1531113 X 5192049 5836941 6928986 7058000 12121035 12894941 13065899 14426054 X 321540 453556 -1190 X false true X true false X 1872259 4199098 3509650 5011182 5620842 20213031 0 0 1872259 4199098 3509650 5011182 5620842 20213031 4684994 15528037 586635 555299 194909 191765 269432 1798040 0 318907 508075 258292 193199 198831 1477304 23488375 2298569 0.66110 0.68630 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 3342500 3342500 3342500 3342500 3342500 3342500 3342500 3342500 3342500 3342500 1.00000 false false false 3363 3363 287213 123495 163718 163718 ASSETS HELD IN TRUST - MUTUAL FUNDS 63794 PERMANENTLY RESTRICTED INVESTMENTS 3342500 Right of use Asset 381165 3787459 Lease Liability 381165 381165 7271673 453556 337650 791206 6480467 6480467 6497767 338840 338840 6158927 6158927 Part V, Line 4: Intended uses of the endowment fund. Permanently restricted funds are allocated as: Annual Research Grant, $800,000;Research and Annual Sutro Lecture, $2,542,000.THE ANNUAL INCOME FROM "THE DR. HENRY A. SUTRO FAMILY GRANT FOR RESEARCH" WILL BE USED FOR SPECIAL INVESTIGATIONS.The Annual income from the The Drs. Henry and Frederick Sutro Memorial Lecture and Research Grant will be used for the Annual Sutro Memorial Lecture and for research. Part XI, Line 2d: Other revenue amounts included in F/S but not included on form 990 Event expenses $338840 Change in value of charitable trust $-1190 Part XII, Line 2d: Other expenses and losses per audited F/S Event expenses $338840 true Europe 0 0 Grants for research Glaucoma research 50000 50000 50000 Europe Glaucoma Research 50000 Wire FMV 1 false false false false false false Part I, Line 2 - Grantmakers Explanation For Monitoring Use of Funds Outside US Organizations are required to report annually on use of funds for research. false EVENTS 523635 523635 338840 523635 523635 338840 338840 184795 true Baylor College of Medicine One Baylor Plaza Houston TX 77030 741613878 50000 0 GLAUCOMA RESEARCH Brigham and Womens Hospital 75 FRancis St Boston MA 02115 042312909 185500 0 GLAUCOMA RESEARCH GLAUCOMA REASERCH & EDUCATION 55 STEVENSON ST SAN FRANCISCO CA 94105 943208182 400000 0 GLAUCOMA RESEARCH Massachusetts Eye & Ear 243 Charles St Boston MA 02114 042103591 150000 0 GLAUCOMA RESEARCH Mayo Clinic PO Box 860334 Minneapolis MN 55486 590714831 150000 0 GLAUCOMA RESEARCH STANFORD UNIVERSITY 485 Broadway Redwood City CA 94063 941156365 50000 0 GLAUCOMA RESEARCH STANFORD UNIVERSITY PO Box 44253 San Francisco CA 94144 941156365 250000 0 GLAUCOMA RESEARCH UC Berkeley 1608 Fourth St Berkeley CA 94710 946002123 200000 0 GLAUCOMA RESEARCH UC DAVIS PO Box 989062 West Sacramento CA 95798 946036494 250000 0 GLAUCOMA RESEARCH UC Irvine 120 Theory Irvine CA 92697 952226406 50000 0 GLAUCOMA RESEARCH UC SAN DIEGO 9500 GILMAN DR MC 0009 LA JOLLA CA 92093 956006144 250000 0 GLAUCOMA RESEARCH UC SAN FRANCISCO PO Box 748872 Los Angeles CA 90074 946036493 250000 0 GLAUCOMA RESEARCH UNIVERSITY OF SOUTHERN CA 1450 BIGGY ST LOS ANGELES CA 90089 951642394 50000 0 GLAUCOMA RESEARCH University of Virginia PO Box 400195 Charlottesville VA 22904 546001796 50000 0 GLAUCOMA RESEARCH WASHINGTON UNIVERSITY 700 Rosedale Ave ST LOUIS MO 63112 430653611 50000 0 GLAUCOMA RESEARCH 15 0 Grantmaker's Description of How Grants are Used Organizations are required to report annually on use of funds for research. X X X X X false false false false false false false false false NANCY GRAYDON E.D. DEVEL. & COO 244991 12500 257491 THOMAS M BRUNNER President & CEO 258086 13140 271226 X 6 90157 FMV false true true Part I, Line 32, Hire and Use of Third Parties Organization uses a third party to sell noncash contributions. Form 990, Part VI, Section B, Line 11b STAFF REVIEW, COPY EMAILED TO BOARD FOR REVIEW/COMMENTS Form 990, Part VI, Section B, Line 12c COMPLIANCE FORMS SENT EVERY JULY Form 990, Part VI, Section B, Line 15a Performance review by Board & Compensation Committee. Compensation Committee uses Salary Surveys and approves CEO compensation at Boards direction. Form 990, Part VI, Section B, Line 15b Annual review by supervisor and approval by next level manager with use of comparability data Form 990, Part VI, Section C, Line 19 UPON REQUEST Form 990, Part XI, Line 9 CHANGE IN VALUE CHARITABLE TRUST = -$1190